Home Overview Press Room Blog Publications For Students about us
Search

Pete Shanks's Publications


Pete Shanks, MA, attended Oxford University, where he studied Philosophy, Politics and Economics, and moved to California in the mid-1970s. He has been active in a range of local and international political movements, while mostly making his living in the publishing industry, especially on the production side; he enjoys the craft of bookmaking. Appalled by the eugenic possibilities of biotechnology, he has worked as a consultant with the Center for Genetics and Society since its earliest days. He is the author of Human Genetic Engineering: A Guide for Activists, Skeptics, and the Very Perplexed (Nation Books) and a regular contributor to Biopolitical Times.

Talking About the Germlineby Pete ShanksBiopolitical TimesJuly 8th, 2015The debate about heritable human genetic modification continues, with opinions ranging from enthusiasm to dismay, and strong arguments for political as well as scientific involvement.
The Science and Ethics of Genetically Engineered Human DNAby Pete ShanksBiopolitical TimesJune 18th, 2015Discussion of germline genetic modification continues, most recently in the House of Representatives Research and Technology Subcommittee, Committee on Science, Space, and Technology.
Reframing "De-extinction" by Pete ShanksBiopolitical TimesMay 28th, 2015Beth Shapiro is advocating for a new definition of "de-extinction" that stresses the ecological niche over genetic identity. She envisages using novel creatures to change entire ecologies.
Stopping or Selling Human Germline Modification?by Pete ShanksBiopolitical TimesMay 7th, 2015Debate about human germline engineering has taken off since publication of a paper describing failed attempts to genetically modify a human embryo.
DARPA, Synthetic Biology and Human Germline Engineering by Pete ShanksBiopolitical TimesApril 9th, 2015The Defense Advanced Research Projects Agency is committed to synthetic biology as one of its four main project areas, and may be involved in human germline experiments.
Hype, Money and Stem Cellsby Pete ShanksBiopolitical TimesApril 9th, 2015Michael Hiltzik of the Los Angeles Times used newly published research to write a scathing article largely focused on the California Institute for Regenerative Medicine.
Babies from Two Bio-Dads?by Pete ShanksBiopolitical TimesRecent research on human germ cells has revived speculation about the possible uses of artificial gametes.
Mitochondrial Mission Creep and the Cloning Connection by Pete ShanksBiopolitical TimesFebruary 14th, 2015Shoukhrat Mitalipov wants to use nuclear genome transfer for age-related infertility. He has joined forces with the disgraced stem cell researcher Hwang Woo-suk.
Precision Medicine in Contextby Pete ShanksBiopolitical TimesFebruary 5th, 2015President Obama's proposal for a Precision Medicine Initiative – which echoes President Nixon's "War on Cancer" – should start a conversation that includes lots of questions.
Who Needs a Synthetic Biological "Safety Lock"? by Pete ShanksBiopolitical TimesFebruary 4th, 2015Two papers published simultaneously in Nature on January 21 describe a novel strategy for biocontainment, involving a strain of E. Coli that is dependent on a synthetic amino acid.
Perils of Artificial Intelligenceby Pete ShanksBiopolitical TimesJanuary 22nd, 2015The Future of Life Institute is calling for "research on how to make AI systems robust and beneficial," on the heels of several warnings about potential dire dangers.
Bad Boy Scientism by Pete ShanksBiopolitical TimesJanuary 8th, 2015Austen Heinz of Cambrian Genomics has been spouting provocative opinions to get attention. And it seems to be working, from his point of view.
CIRM 2.0by Pete ShanksBiopolitical TimesJanuary 7th, 2015The California Institute for Regenerative Medicine is attempting a "reboot" in an effort to accelerate the development of cures, though its critics remain skeptical.
Biopolitical News of 2014by Pete Shanks, Jessica Cussins & Marcy DarnovskyBiopolitical TimesDecember 19th, 2014This is everything important that happened in biopolitics in 2014 (or close to it).
Top Biopolitical Times Posts of 2014by Jessica Cussins & Pete ShanksBiopolitical TimesDecember 18th, 2014In 2014, CGS staffers and contributors posted 107 blogs in Biopolitical Times. These are twelve of our favorites.
CRISPR Opportunities ... For What? And for Whom?by Pete ShanksHuffington PostDecember 10th, 2014Money and deals are flowing into companies that promise to edit genes. Human, animal, plant, all kinds of DNA may be on the cutting board.
CRISPR Opportunities … For What? And For Whom? by Pete ShanksBiopolitical TimesDecember 4th, 2014Money and deals are flowing into the companies founded on CRISPR technology, which promises to enable the precise editing of genomes.
Pigs to Peopleby Pete ShanksBiopolitical TimesNovember 24th, 2014Synthetic biology takes aim at xenotransplantation.
Patently Absurd? Or Absurdly Patentable?by Pete ShanksBiopolitical TimesNovember 12th, 2014The US Supreme Court might agree to rule on the validity of stem-cell patents, and the Canadian courts are being asked to invalidate a patent on disease-linked genes.
Are All Pluripotent Stem Cells Equal?by Pete ShanksBiopolitical TimesNovember 12th, 2014A new paper by long-term advocates of research cloning implies that it has no advantage over reprogramming cells.
Displaying 1-20 of 296  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760